Your World-Class Speaker Faculty

Take a closer look at the 100+ industry-renowned speakers headlining the 16th World Clinical Biomarkers & Companion Diagnostics Summit.

Pharmaceutical Leaders
Technology & AI Innovators
Transformative Charities, Associations, Academics & Clinicians
Biotech Pioneers
Leading Precision Medicine Solution Providers

Pharmaceutical Leaders

Amy Gorman

International Precision Medicine & Diagnostics Commercial Leader
AbbVie

Danielle Townsley

Executive Director & Precision Medicine Therapeutic Area Head, Oncology
Amgen
Dishant Kalra - Expert Speaker

Dishant Kalra

Head, Precision Medicine
Astellas Pharma

Diarmuid Moran

Head of Precision Medicine & Diagnostics (R&D)
Astellas Pharma

Mark Gustavson

Senior Director, Computational Pathology
AstraZeneca

John W. Longshore

Vice President, Scientific Affairs, Global Oncology Diagnostics
AstraZeneca

Etai Jacob

Head, Applied Data Science & AI, Oncology R&D
AstraZeneca

Adriana Racolta

Senior Director, Global Regulatory Leader, IVD
Bayer

Jon Baden

Executive Director & Head, Precision Medicine
Bristol Myers Squibb

Jilian Golding

Global Commercial Strategy, Precision Medicine Lead
Bristol Myers Squibb

Christina Bender

Director, Global Oncology Marketing, Biomarker Strategy
Daiichi Sankyo

Amy H. Kao

Senior Vice President, Global Head, Research Unit, & Neuroscience, Immunology & Billerica Campus Head
EMD Serono the Healthcare Business of Merck KGaA

Zheng Feng

Head, Clinical Genomics, Clinical Measurements Sciences
EMD Serono, the Healthcare Business of Merck KGaA, Darmstadt, Germany

Lauri Diehl

Executive Director, Research Pathology
Gilead Sciences

Cecilia Schott

Vice President & Head, Precision Diagnostics, Oncology Translational Medicine R&D
GSK

Mike Washburn

Executive Director & Head, Integrative Sciences, Oncology Translational Medicine
GSK

Angela Silvestro

Director, Companion Diagnostics
GSK

Neeraj adya

Head, Diagnostics, Immunology
J&J Innovative Medicine

Andrea Stevens

Senior Director, Precision Medicine Access
Johnson & Johnson Innovative Medicine

Viraj Tyagi

Global Alliance Leader, Strategic Partnering, Precision Medicine & Diagnostics
Johnson & Johnson Innovative Medicine

Fernando Cruz-Guilloty

Director, Oncology Precision Medicine & Diagnostics
Johnson & Johnson Innovative Medicine

Neha Kumar

Senior Director, Global Commercial Precision Medicine Strategy
Johnson & Johnson Innovative Medicine & Incoming Director-at-Large, National Society of Genetic Counselors

Sid Mathur

Executive Director, Regulatory Diagnostics & Digital Health (RDDH)
Merck

Carol Peña

Associate Vice President, Companion Diagnostic Development
Merck

Karim Azer

Global Head, Data & AI, Clinical Development
Novartis

Nancy Krunic, Ph.D

Vice President & Precision Medicine Head, Diagnostic Sciences & Partnerships
Novartis

Wendy Valenius

Director, Global Regulatory Strategy, Companion Diagnostics
Pfizer

Benjamin Withey

Director, Commercial Diagnostics - CDx Lead
Pfizer

Jessica Falcon

Manager, Clinical Diagnostics
Regeneron

Emanuele De Rinaldis

Vice President & Global Head, Target, Diseases & Systems Biology
Sanofi

Alina Ainbinder

Scientific Associate Director
Takeda

Christoph Menzel

Head, Companion Diagnostics & Biomarker Strategy
The Healthcare Business of Merck KGaA, Darmstadt, Germany

Technology & AI Innovators

David Henderson

Customer Engineer III AI/ML, Life Sciences North
Google Cloud

Alexander Mehmet Ersoy

Director, Industry Advisory, Healthcare & Life Sciences
Microsoft

Transformative Charities, Associations, Academics & Clinicians

Lauren Leiman

Executive Director
BLOODPAC

Chris Fidyk

Executive Vice President, Business Development
Crohn’s & Colitis Foundation

Caroline Koffke

Director, Educational & Healthcare Provider Programs
Living Beyond Breast Cancer

Michael Berger

Co-Director, Marie Josee & Henry Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center

Mark Ewalt

Associate Medical Director, Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service
Memorial Sloan Kettering Cancer Center

Lee Cooper

Professor & Director, Computational Division, Department of Pathology
Northwestern University

Haley Director

Board of Directors, Policy
Rare New England

Tasia Rechisky

Board of Directory, Secretary, Policy Co-Lead, Rare Disease Patient & Advocate
Rare New England

Jill Weimer

Senior Director, Therapeutic Development
Sanford Research

Jim Palma

Chief Executive Officer
TargetCancer Foundation

Marshall Thompson

Chief Technology Officer
The Rare Cancer Research Foundation

Matthew G.Hanna

Vice Chair, Pathology Informatics
University of Pittsburgh Medical Center

Biotech Pioneers

Chloe Delepine

Director, Clinical Biomarkers
Agenus

Shruti Vij

Director, Innovation & AI Strategy
Alexion Pharmaceuticals

Michael Stocum

President & Chief Executive Officer
Bantam Pharmaceutical LLC

Priya S. Chockalingam

Vice President & Head, Clinical Bioanalytics & Translational Sciences
Beam Therapeutics

Francesca Barone

Chief Scientific Officer
Candel Therapeutics

Kris Sachsenmeier

Vice President, Translational Sciences
Compass Therapeutics

Heather Cohen

Vice President, Precision Medicine & Biomarkers
CREATE Medicines

Jarema Kochan

Senior Director, Clinical Biomarkers, Clinical Development
Eikon Therapeutics

Kathryn Newhall

Executive Director, Translational Biomarkers & Diagnostics
Immunome

John Goldberg

Acting Chief Development Officer
Incendia Therapeutics

Jeff Jackson

Group Vice President, Translational Medicine
Incyte Corporation

Robin Edwards

Vice President, Translational Medicine
MacroGenics

Marla Weetall

Senior Vice President, Pharmacology & Biomarkers
PTC Therapeutics

Marsha Crochiere

Vice President, Translational Medicine & Research
Pyxis Oncology

Scott Yohe

Senior Vice President, Managed Markets & Access Strategy
Rigel Pharmaceutical

Marie Du

Executive Director, Biomarker & Translational Operations
Vanqua Bio

Leading Precision Medicine Solution Providers

Erin Grath

Associate Vice President, Regulatory Affairs
Agilent Technologies

Zhen Mahoney

Director, Companion Diagnostics Business Development
Agilent Technologies

Stewart McWilliams

Global Vice President, Quality & Regulatory Affairs
Almac Diagnostic Services

Matthew Pink

Vice President, Business Development
Biodesix

Michael Chen

Senior Translational Medicine Scientist
Burning Rock Dx

Carla Kantara

Vice President & Head, Global Biopharma Business Development & Precision Partnering
Caris Life Sciences

Christopher Ung

Chief Scientific & Business Officer
CellCarta

Gulfem Guler

Vice President, Translational Research
ClearNote Health

T. Scott Reid

Vice President & Global Head of Companion Diagnostics
Discovery Life Sciences Inc

Matthew Maland

Director, Regulatory Affairs
EntroGen

Varun Pattani

Senior Director & Head of Diagnostic Development
Foundation Medicine

Eric Fung

Senior Vice President, Clinical Development, Population Health & Biostatistics
GRAIL

Siraj Ali

Global Vice President, Translation Medicine
Lunit

Patrick Frey

Vice President, Precision Medicine
MindPeak GmbH

Hosein Kouros-Mehr

Senior Vice President, R&D
Myriad Genetics

Christine Federovitch

Head, Regulatory Affairs, IVD
Navigate BioPharma

Hedi Ben Brahim

Chief Executive Officer
One Biosciences

Ben Glass

Senior Vice President, Product, Research & AI
PathAI

Pierre Moulin

Chief Scientific Officer
Patholytix
Mark Roberts - Expert Speaker

Mark Roberts

Chief Operating Officer
Pearl Pathways, part of Versiti Clinical Trial Services

Assaf Kacen

Co-Founder & Chief Technology Officer
Promise Bio

Julien Pontis

Head, Companion Diagnostics & Clinical Diagnostics
Sophia Genetics

Kate Sasser

Chief Scientific Officer
Tempus

Scott Bornheimer

Director Medical Affairs & CDx
Waters Corporation
2
Explore the New Agenda

Hear the latest imaging, multi-omics, single-cell and functional assays, enhanced by AI-driven digital biomarker strategies, enabling earlier and smarter treatment decisions for oncology, autoimmune, neurological, chronic and rare disease patients

View the Presentation & Speaker Line-Up
CDx Europe - Networking Page
Partner with Us

Position your solutions alongside leading biomarker, diagnostic and technology providers, to ensure your brand is front and center, and retain your place as the partner of choice in the ever-expanding precision medicine space

View Partnership Options
1
Join 850+ Specialist Experts

Be part of the liveliest Rx-Dx conversations with like-minded industry peers spanning a range of precision therapy modalities, and build high-value connections during dedicated networking sessions designed to foster collaborations

Register Now